Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Prediction of benefit from combined chemotherapy and the antiepidermal growth factor receptor cetuximab is a not yet solved question in head and neck squamous cell carcinoma (HNSCC). In a selected series of 14 long progression-free survival (PFS) and 26 short PFS patients by whole gene and microRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossi, Paolo, Siano, Marco, Bergamini, Cristiana, Cossu Rocca, Maria, Sponghini, Andrea P., Giannoccaro, Marco, Tonella, Luca, Paoli, Alessandro, Marchesi, Edoardo, Perrone, Federica, Pilotti, Silvana, Locati, Laura D., Canevari, Silvana, Licitra, Lisa, De Cecco, Loris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702394/
https://www.ncbi.nlm.nih.gov/pubmed/29259349
http://dx.doi.org/10.1155/2017/6870614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702394/
https://www.ncbi.nlm.nih.gov/pubmed/29259349
http://dx.doi.org/10.1155/2017/6870614

Ejemplares similares